FDA sued for not acting on petition about antidepressant harms

It has been six years since FDA was petitioned to update antidepressant labels but so far, the agency has failed to act.

Do your job!

That’s the message to the Food and Drug Administration (FDA) from Public Citizen, the consumer advocacy group fighting to get warning labels updated on selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).

The popular antidepressants, which are known to have a numbing effect on people, can sometimes result in persistent sexual dysfunction, even after stopping the medication – leading to a rare condition called Post-SSRI Sexual Dysfunction (PSSD).